劉碧娟?張珊華
[摘要] 目的 觀察自擬調(diào)經(jīng)湯合來(lái)曲唑治療多囊卵巢綜合征排卵障礙的臨床療效。方法 將90例患者隨機(jī)分為三組:自擬調(diào)經(jīng)湯合來(lái)曲唑組、單用來(lái)曲唑組、克羅米芬組,B超監(jiān)測(cè)卵泡至排卵,比較三組睪酮(T)、促卵泡素(FSH)、黃體生成素(LH)水平;子宮內(nèi)膜厚度、成熟卵泡數(shù)、排卵率、妊娠率。結(jié)果 自擬調(diào)經(jīng)湯合來(lái)曲唑?qū)π约に馗纳魄闆r、子宮內(nèi)膜厚度影響優(yōu)于單用來(lái)曲唑組和克羅米芬組,成熟卵率、排卵率、妊娠率高于單用來(lái)曲唑組和克羅米芬組(P<0.05),三組對(duì)照有統(tǒng)計(jì)學(xué)差異(P<0.05)。結(jié)論 應(yīng)用自擬調(diào)經(jīng)湯合來(lái)曲唑治療多囊卵巢綜合癥排卵障礙,排卵率、妊娠率較高。
[關(guān)鍵詞] 自擬調(diào)經(jīng)湯;來(lái)曲唑;克羅米芬;多囊卵巢綜合征(PCOS);排卵障礙
[中圖分類號(hào)] R271.14 [文獻(xiàn)標(biāo)識(shí)碼] B [文章編號(hào)] 2095-0616(2016)20-58-03
Self-made menses-regulating decoction combined with Letrozole in treatment of 30 cases of ovulation failure
LIU Bijuan1 ZHANG Shanhua2
1.Department of Obstetrics and Gynecology, Siming Branch of First Affiliated Hospital of Xiamen University, Xiamen 361000, China; 2.Department of Obstetrics and Gynecology, Quanzhou Traditional Chinese Medicine Hospital, Quanzhou 362000,China
[Abstract] Objective To investigate the clinical effect of self-made menses-regulating decoction combined with letrozole in treatment of ovulation disorder in women with polycystic ovary syndrome. Methods 90 cases of patients were randomly divided into three groups: self-made menses-regulating decoction combined with letrozole group, single letrozole group and clomiphene group. Ultrasound was used to monitor the ovarian follicles to ovulation. testosterone(T), follicle stimulating hormone(FSH), luteinizing hormone(LH) levels, endometrial thickness, number of mature follicles, ovulation rate, pregnancy rate of the three groups were compared. Results Effect of sex hormone and endometrial thickness of self-made menses-regulating decoction combined with letrozole group were better than those of single letrozole group and clomiphene group. Mature egg rate, ovulation rate and pregnancy rate of self-made menses-regulating decoction combined with letrozole group were higher than those of single letrozole group and clomiphene group(P<0.05). Conclusion The ovulation rate and pregnancy rate of self-made menses-regulating decoction combined with letrozole in treatment of ovulation disorder in women with polycystic ovary syndrome are high.
[Key words] Self-made menses-regulating decoction; Letrozole; Clomiphene;PCOS; Ovulation failure
1 資料與方法
1.1 一般資料
選定于2013年11月~2015年10月來(lái)我院不孕門(mén)診就診的多囊卵巢排卵障礙不孕癥患者,西醫(yī)診斷標(biāo)準(zhǔn)依據(jù)《婦產(chǎn)科學(xué)》[1]:稀發(fā)排卵或無(wú)排卵;高雄激素的臨床表現(xiàn)和(或)高雄激素血癥;卵巢多囊改變:超聲提示一側(cè)或雙側(cè)卵巢直徑2~9mm的卵泡>12個(gè),和(或)卵巢體積>10mL;三項(xiàng)中符合兩項(xiàng)并排除其他高雄激素病因,如先天性腎上腺皮質(zhì)增生、庫(kù)欣綜合征、分泌雄激素的腫瘤等。中醫(yī)辨證診斷標(biāo)準(zhǔn)參照《中醫(yī)婦科學(xué)》[2]及《中藥新藥臨床研究指導(dǎo)原則》[3]的相關(guān)內(nèi)容制定。子宮輸卵管碘油造影提示至少有一側(cè)輸卵管通暢,男方精液常規(guī)檢查無(wú)異常。治療前 3個(gè)月口服達(dá)英35和二甲雙胍。共選取患者90例,隨機(jī)分為自擬調(diào)經(jīng)湯合來(lái)曲唑組、來(lái)曲唑組、克羅米芬組,每組30例,觀察性激素水平、B超監(jiān)測(cè)卵泡及子宮內(nèi)膜厚度,排卵及妊娠情況,最長(zhǎng)跟蹤觀察6個(gè)周期。三組患者一般資料差異無(wú)顯著性,具有可比性。
1.2 治療方法
1.2.1 自擬調(diào)經(jīng)湯合來(lái)曲唑組 采用自擬的中藥組方按卵泡期、排卵期、黃體期治療,自第5天起,每次200mL,每日2次,分早晚口服,基礎(chǔ)方藥由熟地、山藥、萸肉、菟絲子、茯苓、萊菔子、鹿角霜、仙靈脾組成。卵泡期加滋補(bǔ)腎陰藥物如女貞子、旱蓮草等;排卵期加活血化瘀藥物如當(dāng)歸、川芎、赤芍、皂刺等;黃體期加溫腎補(bǔ)陽(yáng)藥物如紫河車、紫石英、巴戟天等。在中藥治療的同時(shí),于月經(jīng)周期第4天起
加服來(lái)曲唑2.5mg/d,連服5d。
1.2.2 來(lái)曲唑組 于月經(jīng)第4天起口服來(lái)曲唑2.5~5mg/d,連服5d。
1.2.3 克羅米芬組 于月經(jīng)第4天起口服克羅米芬50~100mg/d,連服5d。
1.3 B超監(jiān)測(cè)卵泡
于月經(jīng)周期第10天起B(yǎng)超監(jiān)測(cè)卵泡發(fā)育,若子宮內(nèi)膜厚度不足5mm時(shí),可加服補(bǔ)佳樂(lè)1mg,并根據(jù)子宮內(nèi)膜厚度調(diào)整補(bǔ)佳樂(lè)用量。當(dāng)最大卵泡平均直徑達(dá)到18mm時(shí),肌肉注射絨毛膜促性腺素5000~10 000IU誘發(fā)排卵,并指導(dǎo)同房。絨毛膜促性腺素注射后36~48h經(jīng)B超聲證實(shí)排卵。排卵后第14天測(cè)血清HCG確認(rèn)妊娠,排卵后30d B超見(jiàn)心管搏動(dòng)證實(shí)為臨床妊娠。
1.4 觀察指標(biāo)
(1) 成熟卵泡數(shù):當(dāng)卵泡直徑達(dá)到18mm則為成熟,予以注射絨毛膜促性腺素;(2)內(nèi)膜8mm以上視為達(dá)標(biāo);(3)排卵率=排卵周期數(shù)/治療周期數(shù)×100%;(4) 妊娠率=臨床妊娠例數(shù)/治療例數(shù)×100%。(5)比較三組睪酮(T)、促卵泡素(FSH)、黃體生成素(LH)水平;子宮內(nèi)膜厚度、成熟卵泡數(shù)、排卵率、妊娠率。
1.5 統(tǒng)計(jì)學(xué)方法
組間率比較采用χ2檢驗(yàn),計(jì)量資料比較采用 t 檢驗(yàn)。P<0.05表示差異有統(tǒng)計(jì)學(xué)意義。
2 結(jié)果
三組患者LH、T均有不同程度的下降,自擬調(diào)經(jīng)湯合來(lái)曲唑組患者下降更明顯,自擬調(diào)經(jīng)湯合來(lái)曲唑組療效顯著高于后兩組,差異有統(tǒng)計(jì)學(xué)意義(P<0.05)。見(jiàn)表1~3。
3 討論
來(lái)曲唑是芳香化酶抑制劑,可阻斷98%以上的芳香化酶活性,服藥后血、尿雌激素水平明顯降低,早卵泡期服用可通過(guò)降低雌激素合成,解除雌激素對(duì)垂體的負(fù)反饋抑制,刺激垂體卵泡刺激素(FSH)分泌增多,誘發(fā)卵泡生長(zhǎng)發(fā)育與排卵[3]。與傳統(tǒng)克羅米酚(CC)比較有其優(yōu)越性,逐步取代克羅米芬成為第一線促排卵藥物[4-6]。依據(jù)現(xiàn)代醫(yī)學(xué)把月經(jīng)周期分為月經(jīng)期、卵泡期、排卵期、黃體期不同環(huán)節(jié),結(jié)合中醫(yī)方面關(guān)于女性月經(jīng)周期陰陽(yáng)消長(zhǎng)轉(zhuǎn)化規(guī)律的生理特點(diǎn)自擬調(diào)經(jīng)方。熟地、萸肉、菟絲子、山藥等滋腎養(yǎng)血填精培其本,促進(jìn)氣血充盛、天葵成熟,腎精得以充實(shí),成為卵泡成熟之源,并能刺激卵巢微循環(huán),促發(fā)卵泡發(fā)育成熟,繼而排出卵子;仙靈脾、鹿角霜、巴戟天等疏肝、益陽(yáng)之品,能促使沖任暢達(dá)、陽(yáng)氣施布,成為觸發(fā)排卵的源泉。有研究表明,熟地、當(dāng)歸、皂角刺、白芍能夠緩解多囊卵巢患者的高胰島素血癥、降低高雄激素水平,針對(duì)病因進(jìn)行治療[7]。茯苓、萊菔子化痰祛濁,可改善血液
高凝狀況,矯正多囊卵巢患者的胰島素抵抗,增強(qiáng)胰島素的敏感性,繼而減輕高胰島素血癥及調(diào)節(jié)高雄激素水平,刺激卵巢局部微循環(huán),引發(fā)卵泡的發(fā)育、成熟及排出。補(bǔ)腎中藥能改善矯正下丘腦-垂體-卵巢軸的功能失調(diào),誘發(fā)卵泡發(fā)育與排卵,預(yù)防并減少卵泡黃素化綜合征等并發(fā)癥的發(fā)生[8]?,F(xiàn)代中藥機(jī)制研究表明 ,補(bǔ)腎疏肝中藥主要作用在于調(diào)控機(jī)體內(nèi)分泌功能狀況,促進(jìn)性激素及其受體水平降調(diào)至正常,并提升卵泡質(zhì)量,提高授精率、增加子宮內(nèi)膜對(duì)胚胎容受性等。本中藥自擬方序貫治療與階段用藥相配,滋陰與助陽(yáng)并用,溫腎與疏肝同施,化痰與調(diào)血相合,應(yīng)用中西醫(yī)結(jié)合治療多囊卵巢綜合征排卵障礙療效顯著,能緩和單用來(lái)曲唑?qū)Ω咝奂に匮Y的不足,又能發(fā)揮中醫(yī)藥的特長(zhǎng),提高療效。
[參考文獻(xiàn)]
[1] 謝幸.婦產(chǎn)科學(xué)[M]. 第8版.北京:人民衛(wèi)生出版社,2013:359-362.
[2] 張玉珍.中醫(yī)婦科學(xué)[M].北京:中國(guó)中醫(yī)藥出版社,2007:327-328.
[3] Lamb HM,Adkins JC.Letrozole:a review of its use in postm-enopausal women with advanced breast cancer [J].Drugs,1998,56(6):1125-1140.
[4] Kilic-Okman T, Kucuk M, Altaner S.Comparison of the effects of letrozole and clomiphene citrate on ovarian follicles,endometrium and hormone levels in the rat[J].Fertil Steril,2003,80(6):1330-1332.
[5] Mitwdly MF,Casper RF.Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate[J].Fertil Steril,2001,75(2):305-309.
[6] Fisher SA,Reid RL,Van Vugt DA,et al.A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women[J].Fertil Steril,2002,78(2):280-285.
[7] 周麗蓉,俞瑾.補(bǔ)腎陰藥治療高胰島素高雄激素?zé)o排卵癥的臨床觀察[J].中國(guó)中西醫(yī)結(jié)合雜志,1996,16(9):515-518.
[8] 李希心,蘇明廉.當(dāng)代中藥臨床應(yīng)用[M].濟(jì)南:濟(jì)南出版社,1999:741-796.